Sangamo Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 1,322,529 | 0.635% |
Public Companies | 3,250,000 | 1.56% |
Hedge Funds | 14,060,000 | 6.75% |
Institutions | 66,324,672 | 31.9% |
General Public | 123,263,469 | 59.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
20,090,570 | US$43.3m | -0.21% | 0.18% | |||
14,060,000 | US$30.3m | -17.1% | 0.87% | |||
9,597,642 | US$20.7m | -19.3% | no data | |||
4,702,938 | US$10.1m | -64.6% | no data | |||
4,126,577 | US$8.9m | 58.8% | 0.02% | |||
3,250,000 | US$7.0m | -77.8% | no data | |||
2,950,944 | US$6.4m | 1,440% | 0.03% | |||
2,408,197 | US$5.2m | 118% | no data | |||
2,138,309 | US$4.6m | 14.6% | no data | |||
1,266,239 | US$2.7m | 114% | no data | |||
1,201,047 | US$2.6m | -2.27% | no data | |||
1,165,993 | US$2.5m | -62% | no data | |||
1,103,326 | US$2.4m | 5.46% | no data | |||
1,098,000 | US$2.4m | 0% | 0.27% | |||
820,355 | US$1.8m | -42.6% | no data | |||
792,313 | US$1.7m | 0.51% | no data | |||
775,478 | US$1.7m | 49.9% | no data | |||
744,102 | US$1.6m | 0% | 0.1% | |||
670,118 | US$1.4m | 1,970% | no data | |||
600,637 | US$1.3m | 1,640% | no data | |||
576,219 | US$1.2m | 56.3% | no data | |||
543,194 | US$1.2m | -2.1% | no data | |||
519,221 | US$1.1m | -81.1% | no data | |||
497,519 | US$1.1m | 0% | no data | |||
493,686 | US$1.1m | -4.73% | no data |